This Month In Muscular Dystrophy

Dr. Paul Martin discusses how the CMAH gene deletion in the mdx mouse model of Duchenne Muscular Dystrophy helps better mimic the more severe aspects of DMD

Informações:

Sinopsis

Guest: Paul Martin, PhD, principal investigator, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital Access an abstract of this month’s featured research article: A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med. 2010 Jul 28;2(42):42ra54.